✦ LIBER ✦

A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma

✍ Scribed by William J. Berg; Lawrence H. Schwartz; Alison Amsterdam; Madhu Mazumdar; Vaia Vlamis; Teresa Murray Law; David M. Nanus; Robert J. Motzer

Book ID: 110230301
Publisher: Springer US
Year: 1997
Tongue: English
Weight: 27 KB
Volume: 15
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1005902022076

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of paclitaxel, α-int

Phase II evaluation of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma

✍ Ulka Vaishampayan; Lawrence Flaherty; Wei Du; Maha Hussain 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

A Phase II pilot trial of 13-cis retinoi

A Phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma

✍ Felix H. Brembeck; Klaus Schoppmeyer; Ursula Leupold; Costel Gornistu; Volker Ke 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## BACKGROUND. Advanced unresectable pancreatic adenocarcinoma has a dismal prognosis. The authors previously have shown that retinoic acid (RA) and interferon-␣ (IFN-␣) inhibit growth and induce differentiation in human pancreatic carcinoma cells in vitro and in vivo. The purpose of this trial wa

Phase II clinical trial of 13-cis-retino

Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma

✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo

A phase II study of pyrazoloacridine in

A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma

✍ William J. Berg; John McCaffrey; Lawrence H. Schwartz; Tania Mariani; Madhu Mazu 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 44 KB

A Phase II study of irinotecan in patien

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

✍ Karim Fizazi; Frédéric Rolland; Christine Chevreau; Jean-Pierre Droz; Dominique 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

## Abstract ## BACKGROUND Patients with disseminated renal cell carcinoma (RCC) have a poor outcome, and the disease is considered highly resistant to chemotherapy. Irinotecan is an active drug in the treatment of a number of neoplastic diseases and is not concerned with the multidrug‐resistance p

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views